25 September - 27 September 2019

Meet us at BEBPA

This week we're attending the European Bioassays Conference in Prague

Join us there and let's explore Best Practices for the Best Potency Assays together!

We are very excited to announce that we will be hosting hosting a scientific talk at 09.45 on September 26th during the “Session 2: Hot Topics: Ready-to-Use Cells". The title of the talk is “How to Select and Optimize Characterization Criteria for Assay Ready Cells – A Case Study” presented by Karin Blume, scientist from the Svar Research and Development Team.

Abstract:
Characterization of cultured cell lines for production of biologic material and cell lines used for potency applications are outlined in various guidance documents – but there is an absence of specific instructive information about the requirements for genetically modified cell lines, such as modified cell banks used for production of assay ready cells utilized for e.g. in bioassays, ADCC assays and neutralization assays in GxP applications.

Here we offer examples from 10+ years working in development, validation and production of custom genetically modified cell lines and assay ready cells used in reporter gene assays. Examples will showcase critical aspects of characterization and include lessons learned as well as recommendations on what can be considered as an appropriate level for assay read cells.


Make sure to stop by the Svar Booth while in Prague to meet up with Therese Segerstein - Product Manager iLite, Camilla Duborn - Senior Director Sales & Global Marketing, Karin Blume - Scientist R&D and Libby Naylor - Regional Sales Manager UK.

Learn more about our exiting products and services that can help streamline your drug development and gene therapy projects!

 

Exhibitions Linkedin HT2019-4